NEXGEL, Inc. (NXGL)

USD 4.23

(-10.19%)

Operating Expenses Summary of NEXGEL, Inc.

  • NEXGEL, Inc.'s latest annual operating expenses in 2023 was 4.09 Million USD , up 10.16% from previous year.
  • NEXGEL, Inc.'s latest quarterly operating expenses in 2024 Q2 was 1.41 Million USD , up 31.07% from previous quarter.
  • NEXGEL, Inc. reported a annual operating expenses of 3.6 Million USD in annual operating expenses 2022, up 39.74% from previous year.
  • NEXGEL, Inc. reported a annual operating expenses of 2.57 Million USD in annual operating expenses 2021, up 30.98% from previous year.
  • NEXGEL, Inc. reported a quarterly operating expenses of 1.41 Million USD for 2024 Q2, up 31.07% from previous quarter.
  • NEXGEL, Inc. reported a quarterly operating expenses of 826 Thousand USD for 2023 Q1, up 1.1% from previous quarter.

Annual Operating Expenses Chart of NEXGEL, Inc. (2023 - 2016)

Historical Annual Operating Expenses of NEXGEL, Inc. (2023 - 2016)

Year Operating Expenses Operating Expenses Growth
2023 4.09 Million USD 10.16%
2022 3.6 Million USD 39.74%
2021 2.57 Million USD 30.98%
2020 1.96 Million USD 10.18%
2019 1.78 Million USD -25.6%
2018 2.4 Million USD 115.23%
2017 1.11 Million USD -36.23%
2016 1.75 Million USD 0.0%

Peer Operating Expenses Comparison of NEXGEL, Inc.

Name Operating Expenses Operating Expenses Difference
Akoya Biosciences, Inc. 104.27 Million USD 96.072%
AngioDynamics, Inc. 252.41 Million USD 98.377%
AtriCure, Inc. 327.05 Million USD 98.748%
Avinger, Inc. 18.63 Million USD 78.023%
Azenta, Inc. 336.26 Million USD 98.782%
BioLife Solutions, Inc. 117.57 Million USD 96.516%
The Cooper Companies, Inc. 1.82 Billion USD 99.776%
Daxor Corporation 1.28 Million USD -219.871%
Ekso Bionics Holdings, Inc. 24.19 Million USD 83.068%
Femasys Inc. 15.2 Million USD 73.053%
GlucoTrack, Inc. 7.1 Million USD 42.342%
Harvard Bioscience, Inc. 58.58 Million USD 93.008%
Hologic, Inc. 1.34 Billion USD 99.696%
ICU Medical, Inc. 717.04 Million USD 99.429%
Intuitive Surgical, Inc. 2.96 Billion USD 99.862%
KORU Medical Systems, Inc. 26.1 Million USD 84.311%
LeMaitre Vascular, Inc. 90.33 Million USD 95.466%
Innovative Eyewear, Inc. -119.32 Thousand USD 3532.527%
Innovative Eyewear, Inc. -119.32 Thousand USD 3532.527%
Masimo Corporation 867 Million USD 99.528%
Microbot Medical Inc. 9.85 Million USD 58.437%
Meihua International Medical Technologies Co., Ltd. 18.42 Million USD 77.763%
Merit Medical Systems, Inc. 459.92 Million USD 99.109%
Nephros, Inc. 9.78 Million USD 58.136%
NovoCure Limited 613.92 Million USD 99.333%
NEXGEL, Inc. 4.09 Million USD 0.0%
Singular Genomics Systems, Inc. 102.24 Million USD 95.994%
OraSure Technologies, Inc. 125.34 Million USD 96.732%
Pro-Dex, Inc. 7.37 Million USD 44.484%
Pulse Biosciences, Inc. 43.57 Million USD 90.6%
Predictive Oncology Inc. 15.22 Million USD 73.105%
Precision Optics Corporation, Inc. 8.52 Million USD 51.937%
QuidelOrtho Corporation 1.35 Billion USD 99.698%
Repligen Corporation 261.12 Million USD 98.431%
Sanara MedTech Inc. 61.12 Million USD 93.299%
STAAR Surgical Company 224.55 Million USD 98.176%
Sharps Technology, Inc. 10.12 Million USD 59.552%
Utah Medical Products, Inc. 13.26 Million USD 69.112%
DENTSPLY SIRONA Inc. 1.79 Billion USD 99.772%
Jin Medical International Ltd. 3.91 Million USD -4.555%